This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Laser Surgery  • Alert me on articles by topic

Arch Otolaryngol Head Neck Surg. 2002;128:787-788.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

RECURRENT RESPIRATORY papillomatosis (RRP) is a chronic disease of viral origin and the most common benign neoplasm of the larynx in children. However, it is still quite rare, with an incidence (new cases per year) of 0.36 to 1.11 per 100 000 and a prevalence (all cases in a year) of 1.69 to 2.59 per 100 000 in children younger than 18 years.¹ Extrapolated to the US population, an estimated 80 to 1500 incident cases and 700 to 3000 prevalent cases occur in the United States each year in children younger than 18 years. Even at a tertiary care center, no single physician or center has sufficient numbers of patients to embark on randomized trials of new interventions to investigate their efficacy.

In this issue of the ARCHIVES, Pashley² reports the results of a series of patients who received locally injected mumps vaccine in addition to serial carbon dioxide laser excision of . . . [Full Text of this Article]

RELATED ARTICLE

Can Mumps Vaccine Induce Remission in Recurrent Respiratory Papilloma?
Nigel R. T. Pashley
Arch Otolaryngol Head Neck Surg. 2002;128(7):783-786.
ABSTRACT | FULL TEXT